If you've been reading about hormone therapy for perimenopause or menopause, you already know the headline: transdermal estradiol — delivered through the skin — carries a lower clot and stroke risk than oral estrogen because it bypasses the liver's first-pass metabolism (Vinogradova et al., BMJ 2019).

What gets glossed over is that "transdermal" is not one thing. A twice-weekly patch, a daily gel pump, and a pellet implanted every three to six months are three very different pharmacologic experiences. Choosing between them is less about which is "best" and more about which trade-offs you can live with.

How transdermal estradiol actually works

Estradiol molecules are small and lipophilic, which means they cross skin readily and enter systemic circulation without a detour through the portal vein. That single detail explains most of transdermal's safety advantage over oral estrogen: no first-pass hepatic surge in clotting factors, SHBG, or triglycerides.

The NAMS 2022 position statement now recommends transdermal delivery as the preferred route for most women initiating systemic estrogen therapy, especially those with elevated cardiometabolic or VTE risk (The Menopause Society, 2022).

So the route question is largely settled. The remaining question — and it's the one that determines your day-to-day experience — is the delivery vehicle.

The estradiol patch: steady and predictable

A matrix patch (brand or generic) delivers a set microgram-per-day dose — typically 0.025 to 0.1 mg/day — over 3.5 or 7 days depending on the product. You change it once or twice a week.

What the pharmacokinetics look like in practice: relatively flat serum estradiol levels, usually landing in the 40–100 pg/mL range at standard doses. That flatness is the patch's biggest clinical strength. Symptom control tends to be smooth without the peaks and troughs that drive breakthrough hot flashes or mood swings.

The trade-offs:

  • Adhesion issues. Sweat, humidity, sunscreen, and certain body sites (lower back, hip) can shorten wear time. Some patients cycle through two patches a week because one falls off in the shower.
  • Skin reactions. Roughly 5–10% of users develop localized irritation at the adhesive site. Rotating sites helps.
  • Dose granularity is limited. You get whatever strengths the manufacturer makes. Fine-tuning between 0.05 and 0.075, for example, means cutting patches (which the FDA doesn't officially endorse for matrix patches, though some clinicians allow it) or layering.

Patches are the workhorse of modern menopausal HRT — well-studied, insurance-friendly, and forgiving of missed doses because a single day's lapse barely moves serum levels.

Estradiol gel and spray: daily but flexible

Transdermal gels (metered pumps or single-dose packets) and sprays deliver estradiol you rub or spritz onto the arm, thigh, or inner wrist each morning. Standard dosing runs 0.25–1.5 mg per day depending on product.

Pharmacokinetics: more of a daily peak-and-trough than the patch, but far smoother than oral. Serum levels rise within a few hours of application and taper over 24 hours. At equivalent doses, gels can achieve comparable symptom control to patches (Archer, Menopause 2003).

Where gels shine:

  • Dose titration. You can adjust by half-pumps or fractional packets. This matters when you're chasing a therapeutic window and the next patch strength up is too much.
  • No adhesive. Skin-sensitive patients often prefer gel.
  • Discreet. Nothing to see or feel.

Where gels get annoying:

  • Transfer risk. Gel can rub onto partners, children, or pets before it fully absorbs. Manufacturers require 1–2 hours of dry time and covered skin. This is a real, documented issue with pediatric exposure — not a theoretical one.
  • Daily adherence. Miss two days and levels drop meaningfully. Miss a week and vasomotor symptoms return.
  • Absorption variability. Skin thickness, hydration, and application site all shift how much estradiol you actually get. Two people on the same dose can land 30 pg/mL apart.
If you like the idea of adjusting your dose in small increments and don't want anything stuck to your skin, gel is often the better fit — as long as daily consistency is realistic for you.

Estradiol pellets: convenient but hard to reverse

Pellets are compressed estradiol (sometimes combined with testosterone) inserted subcutaneously — usually in the upper buttock — during a brief in-office procedure. They release hormone continuously for three to six months.

The appeal is obvious: no daily dose, no patch to change, no gel to rub in. For patients who hate adherence tasks, this can sound ideal.

The clinical reality is more complicated.

The pharmacokinetic problem. Multiple studies have documented that pellet insertion frequently produces supraphysiologic estradiol levels — sometimes 200–400 pg/mL or higher — well above the premenopausal range (Jiang et al., Menopause 2019). Levels then decline unpredictably over months. You can't lower the dose once the pellet is in.

The FDA position. No estradiol pellet is FDA-approved as a finished product; they are exclusively compounded. That's not automatically disqualifying — many effective therapies are compounded — but it does mean the specific pellet you receive has not been through FDA bioequivalence testing.

The reversibility problem. If side effects appear (breast tenderness, breakthrough bleeding, mood changes, headache), you're waiting weeks to months for levels to fall. With patches and gels, you stop for 48 hours and reassess.

Where pellets can make sense: patients who have tried patches and gels, tolerated them well, know their responsive dose range, and simply want fewer touchpoints with their protocol. It should not be a first-line choice.

{callout: The clinical bottom line} For most women starting systemic estrogen therapy, a patch or gel offers better pharmacokinetic control, easier reversibility, and a cleaner safety profile than pellets — reserve pellets for patients whose response is already characterized.

What about progesterone?

If you have a uterus, systemic estradiol — by any route — requires endometrial protection with a progestogen. Micronized oral progesterone taken at bedtime is the most common pairing. This applies equally to patches, gels, and pellets. Skipping this step is not optional; unopposed estrogen raises endometrial cancer risk substantially.

Labs worth having before a serious protocol

You don't need a lab draw to know you have hot flashes. But if you're building a protocol you plan to stay on for years, the markers worth having a baseline on are:

  • Estradiol (sensitive assay) and FSH — confirms menopausal status and gives a reference point for later dosing
  • Total and free testosterone, SHBG — often part of the same conversation, especially if libido or energy are concerns
  • TSH and free T4 — thyroid dysfunction mimics a lot of menopausal symptoms
  • Lipid panel, fasting glucose, HbA1c — cardiometabolic baseline
  • CBC and comprehensive metabolic panel — general health screen

A thorough workup would typically include these before initiating and then a follow-up estradiol level 6–12 weeks in to confirm you're in a therapeutic window. If you choose to run labs through us, these are the markers our clinicians tend to review first when reading a menopausal HRT case.

So which one should you pick?

The honest answer is that patches and gels are both reasonable first-line choices, and the decision often comes down to lifestyle:

  • Choose a patch if you want the flattest hormone curve, you don't want to think about a daily task, and adhesive on your skin doesn't bother you.
  • Choose a gel if you need fine dose control, you have skin sensitivity to adhesives, or transfer risk to household members is manageable.
  • Consider pellets only after you've established a responsive dose on a titratable route and you understand the reversibility limitation.

Whichever route you choose, the goal is the same: symptom relief at the lowest effective serum estradiol level, paired with endometrial protection if indicated, and reassessed periodically as your body and life change.

Hormone therapy is not set-and-forget. It's a protocol that gets tuned to your numbers, your symptoms, and the trade-offs you're actually willing to make.

Ready to feel like yourself again?

Hormone therapy, built around your bloodwork.

Bioidentical estradiol and progesterone protocols, prescribed by a US-licensed clinician based on a real hormone panel — not a 5-question quiz.

Start your HRT consult →

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a US-licensed clinician before starting or changing any therapy.